Abstracts Archive - Page 2120 of 2425 - ACR Meeting Abstracts

Abstract Number: 1983 • 2013 ACR/ARHP Annual Meeting
Prevalence Of Birefringent Crystals In Three Inflammation-Prone Tissues
Jane Park¹, Divya Soman², Martine P. Roudier³ and Peter A. Simkin⁴, ¹Rheumatology, University of Washington, Seattle, WA, ²University of Washington, Seattle, WA, ³Pathology, University of Washington, Seattle, WA, ⁴Div of Rheumatology, University of Washington, Seattle, WA
Background/Purpose: When serum is hyperuricemic, so too are all interstitial fluids other than CSF and sweat. Anecdotally, urate crystals deposit as grossly visible tophi in…
Abstract Number: 1984 • 2013 ACR/ARHP Annual Meeting
Impact Of Educational Attainment On Health-Related Quality Of Life and Healthcare Utilization Among Veterans With Gout
Cleopatra Aquino-Beaton¹, Jay E. Persselin², Ari Weinreb¹, Meika A Fang¹, Jasvinder A. Singh^3,4, Erin Duffy⁵, David Elashoff⁶, Puja Khanna^7,8 and Dinesh Khanna⁹, ¹Rheumatology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, ²Medicine W-111J Div of Rheum, VA Greater Los Angeles Healthcare System, Los Angeles, CA, ³Department of Medicine, University of Alabama, Tuscaloosa, AL, ⁴Rheumatology, Birmingham VA, Birmingham, AL, ⁵Medicine, University of California Los Angeles, Los Angeles, CA, ⁶Medicine- Statistic Core, UCLA Department of Medicine Statistics Core, Los Angeles, CA, ⁷Division of Rheumatology/Dept. of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, ⁸Rheumatology, Ann Arbor VA, Ann Arbor, MI, ⁹Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI
Background/Purpose: Gout is a debilitating, chronic disease that requires ongoing treatment and effective self-management. Successful gout treatment depends on multiple factors, including educational attainment. Adequate…
Abstract Number: 1985 • 2013 ACR/ARHP Annual Meeting
Prescription Patterns Of Colchicine Before and After Food and Drug Administration Approval
Eswar Krishnan¹, Jasvinder A. Singh² and Linjun Chen¹, ¹Medicine, Stanford University, Palo Alto, CA, ²Department of Medicine, University of Alabama, Tuscaloosa, AL
Background/Purpose: Colchicine, a commonly used drug, had never been subjected to rigorous safety and efficacy studies prior to 2009, when under Hatch-Waxman ACT (1984) and…
Abstract Number: 1986 • 2013 ACR/ARHP Annual Meeting
Colchicine Use and The Risk Of Myocardial Infarction Among Gout Patients: Results From a Community-Based, Informatics-Driven Retrospective Cohort Study
Daria B. Crittenden¹, Binita Shah², Steven P. Sedlis², Christopher J. Swearingen³, Eric S. Wagner⁴, Yvette M. Henry⁴, Peter B. Berger⁴, Bruce N. Cronstein¹ and Michael H. Pillinger⁵, ¹Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY, ²NYU School of Medicine, Division of Cardiology, New York, NY, ³Pediatric Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, ⁴Geisinger Health System, Cardiovascular Center for Clinical Research, Danville, PA, ⁵NYU School of Medicine, Division of Rheumatology, New York, NY
Background/Purpose: Gout patients have an increased risk of myocardial infarction (MI). Since atherosclerosis and plaque rupture are inflammatory processes, anti-inflammatory gout medications might also reduce…
Abstract Number: 1987 • 2013 ACR/ARHP Annual Meeting
LIVER Outcomes In Gout Patients Treated With Febuxostat and Altered LIVER Function TESTS
Fernando Perez-Ruiz^1,2 and Ana M. Herrero-Beites^2,3, ¹Servicio de Reumatologia, Hospital Universitario Cruces, Baracaldo, Spain, ²BioCruces Health Research Institute, Baracaldo, Spain, ³Physical Medicine Division, Hospital de Gorliz, Gorliz, Spain
LIVER OUTCOMES IN GOUT PATIENTS TREATED WITH FEBUXOSTAT AND ALTERED LIVER FUNCTION TESTSBackground/Purpose: patients with significantly altered liver function test (LFTs) at screening do not…
Abstract Number: 1988 • 2013 ACR/ARHP Annual Meeting
Self-Reported Gout, Comorbidities and Healthcare Resource Utilization Data From The 2012 United States National Health and Wellness Survey
Jasvinder A. Singh¹, Kathy Annunziata² and Puja Khanna³, ¹Department of Medicine, University of Alabama, Tuscaloosa, AL, ²Kantar Health, Princeton, NJ, ³Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI
Background/Purpose: Hyperuricemia and gout are associated with major cardiovascular and metabolic comorbidities. Recently published data on comorbidities and gout epidemiology in the US have been…
Abstract Number: 1958 • 2013 ACR/ARHP Annual Meeting
Does Evaluation Of Hand Bone Loss By Digital x-Ray Radiogrammetry Within The First 3 Months After Diagnosis Of Rheumatoid Arthrits Identify Patients At Risk For Radiological Progression?
Ewa H. Berglin¹ and Solbritt M. Rantapaa-Dahlqvist², ¹Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Umeå, Sweden, ²Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Umeå, Sweden, Umea, Sweden
Background/Purpose: To evaluate the usefulness of assement of hand bone loss in prediction of radiological progression in patients with early rheumatoid arthritis (RA). Methods: Patients…
Abstract Number: 1949 • 2013 ACR/ARHP Annual Meeting
Assessment Of Wrist Joint Inflammation In Patients With Rheumatoid Arthritis By Quantitative Two- and Three-Dimensional Power Doppler Ultrasonography
Hsin-Hua Chen, Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; nstitute of Public Health and Community Medicine Research Center, National Yang-Ming University, Taipei, Taiwan
Background/Purpose: To assess the intra-operator and inter-operator reliability of two-dimensional (2D) and three-dimensional (3D)-power Doppler ultrasonography (PDUS) computer-aided quantification data for wrist joint vascularity.Methods: This…
Abstract Number: 1950 • 2013 ACR/ARHP Annual Meeting
Relationship Between Radiographic Joint Space Narrowing, Sonographic Cartilage Thickness and Anatomy In Rheumatoid Arthritis and Control Joints
Peter Mandl¹, Gabriela Supp², Gabor Baksa³, Daniel Aletaha⁴, Reka Kurucz⁵, Dora Niedermayer⁶, Helga Radner⁷, Paul Studenic⁸, Peter V. Balint⁹ and Josef S. Smolen¹⁰, ¹Medical University of Vienna, Vienna, Austria, ²Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ³Semmelweis University, Budapest, Hungary, ⁴Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria, ⁵National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, ⁶PsAID taskforce, EULAR, Zurich, Switzerland, ⁷Department of Internal Medicine III; Division of Rheumatology, Medical University Vienna, Vienna, Austria, ⁸Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ⁹Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, ¹⁰Medical University of Vienna and Hietzing Hospital, Vienna, Austria
Background/Purpose: To validate ultrasound (US) for measuring cartilage thickness, by evaluating cartilage thickness on cadaver specimens of metacarpophalangeal (MCP) joints by US and conventional measurement.…
Abstract Number: 1951 • 2013 ACR/ARHP Annual Meeting
The Spring Ligament Window: A Unique Sonoanatomic View Into a Complex Rheumatoid Joint
Joanne Kitchen¹, I. Moller², Maribel Miguel-Perez³ and David A. Bong⁴, ¹Instituto Poal de Reumatolgia, Barcelona, Spain, ²Instituto Poal, Barcelona, Spain, ³University of Barcelona, Barcelona, Spain, ⁴Instituto Poal de Reumatologia, Barcelona, Spain
Background/Purpose: The calcaneonavicular or spring ligament (SL) is a group of 3 stout non-elastic fibrocartilaginous bands in the medial mid-foot that is important in maintaining…
Abstract Number: 1952 • 2013 ACR/ARHP Annual Meeting
The Value Of An Automated Ultrasound System In The Detection Of Synovitis
Ruediger Mueller¹, Mathias Gruenke², Joerg Wendler³, Florian Schuch³, Karina Hofmann-Preiss⁴, Ina Boettger⁴, Ruediger Jakobs⁵, Hendrik Schulze-Koops⁶ and Johannes von Kempis¹, ¹Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, ²Division of Rheumatoloy, Medizinische Klinik IV, University of Munich, Munich, Germany, ³Schwerpunktpraxis Rheumatologie, Erlangen, Germany, ⁴Institut für bildgebende Diagnostik und Therapie, Erlangen, Germany, ⁵Siemens AG, Erlangen, Germany, ⁶Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany
Background/Purpose: The detection of joint swelling caused by synovitis is important for the diagnosis and assessment of inflammatory arthritis. Ultrasound (US) and MRI have proven…
Abstract Number: 1953 • 2013 ACR/ARHP Annual Meeting
The Progression of Cartilage Damage in Rheumatoid Arthritis: A Three Year Prospective 3T- Magnetic Resonance Imaging Study Examining Predictive Factors
Fiona M. McQueen¹, Alexandra McHaffie², Andrew Clarke², Arier Lee³, Quentin Reeves², Barbara Curteis¹ and Nicola Dalbeth⁴, ¹Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, ²Radiology, Auckland District Health Board, Auckland, New Zealand, ³Biostatistics and Epidemiology, University of Auckland, Auckland, New Zealand, ⁴Auckland District Health Board, Auckland, New Zealand
Background/Purpose: Cartilage damage impacts on patient disability in RA. The aims of this MRI study were to investigate cartilage damage over 3 years and determine…
Abstract Number: 1954 • 2013 ACR/ARHP Annual Meeting
advantages Of a Combined Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) For Hand and Feet: Does The Ramris Of The Hand Alone Underestimate Disease Activity and Progression?
Dr. Philipp Sewerin¹, Dr. Christian Buchbender², Dr. Stefan Vordenbäumen¹, Dr. Axel Scherer², Dr. Falk Miese², Dr. Ralph Brinks³, Dr. Hans-Jörg Wittsack⁴, Prof. Dr. Gerald Antoch⁴, Prof. Dr. Matthias Schneider³ and Prof. Dr. Benedikt Ostendorf¹, ¹Department of Rheumatology, Univ. Duesseldorf, Düsseldorf, Germany, ²Department of Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany, ³Department of Rheumatology, Univ. Duesseldorf, Duesseldorf, Germany, ⁴Department Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany
Background/Purpose: To evaluate a combined rheumatoid arthritis magnetic resonance imaging score (RAMRIS) for hand and foot (HaF-score) in rheumatoid arthritis (RA). Methods: Magnetic resonance imaging…
Abstract Number: 1955 • 2013 ACR/ARHP Annual Meeting
Biochemical MRI With Gagcest (Glycosaminoglycan Chemical Exchange Saturation Transfer Imaging) Of Finger Joint Cartilage In Rheumatoid Arthritis
Dr. Philipp Sewerin¹, Dr. Christoph Schleich², Prof. Dr. Benedikt Ostendorf¹, Dr. Stefan Vordenbäumen¹, Prof. Dr. Gerald Antoch³, Prof. Dr. Matthias Schneider⁴ and Dr. Falk Miese⁵, ¹Department of Rheumatology, Univ. Duesseldorf, Düsseldorf, Germany, ²Department of Diagnostic and Interventional Radiology, Univ. Duesseldorf, Duesseldorf, Germany, ³Department Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany, ⁴Department of Rheumatology, Univ. Duesseldorf, Duesseldorf, Germany, ⁵Department of Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany
Background/Purpose: Rheumathoid arthritis (RA) predominantly involves finger joints. Cartilage damage promotes synovitis and has previously been shown to be predictive for bone erosions. gagCEST has…
Abstract Number: 1956 • 2013 ACR/ARHP Annual Meeting
The Effect Of Initial Methotrexate Therapy On Cartilage Composition In Early Rheumatoid Arthritis: Follow-Up With Biochemical MRI Of Finger Cartilage
Dr. Philipp Sewerin¹, Dr. Falk Miese², Dr. Hans-Jörg Wittsack³, Dr. Stefan Vordenbäumen¹, Dr. Christoph Schleich⁴, Prof. Dr. Gerald Antoch³, Prof. Dr. Matthias Schneider⁵ and Prof. Dr. Benedikt Ostendorf¹, ¹Department of Rheumatology, Univ. Duesseldorf, Düsseldorf, Germany, ²Department of Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany, ³Department Diagnostic and Interventional Radiology, Univ. Duesseldorf, Düsseldorf, Germany, ⁴Department of Diagnostic and Interventional Radiology, Univ. Duesseldorf, Duesseldorf, Germany, ⁵Department of Rheumatology, Univ. Duesseldorf, Duesseldorf, Germany
Background/Purpose: To test for initial status and subsequent recovery of cartilage glycosaminoglycane content in metacarpophalangeal joints (MCP) in patients with early rheumatoid arthritis (eRA) undergoing…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].